Compounds > epigallocatechin gallate
Page last updated: 2024-08-24

epigallocatechin gallate and Esophageal Neoplasms

epigallocatechin gallate has been researched along with Esophageal Neoplasms in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (8.33)18.2507
2000's3 (25.00)29.6817
2010's6 (50.00)24.3611
2020's2 (16.67)2.80

Authors

AuthorsStudies
Chen, Z; Lin, X; Teng, Q; Wei, Y; Wu, F; Zheng, Y; Zhou, F; Zhu, H1
Kong, L; Li, X; Meng, X; Wang, Y; Xie, P; Xing, L; Yu, J; Zhang, Y; Zhao, H; Zhu, W1
Ju, Y; Liu, L; Wang, J; Zhou, R1
Cai, ZY; Liang, YR; Lu, JL; Shi, YL; Wang, KR; Wang, LX; Xiang, LP; Ye, JH; Zhang, LJ; Zheng, XQ1
Chen, YC; Gao, Y; Jia, L; Li, B; Li, W; Tu, Y1
Akanuma, N; Akutsu, Y; Hanari, N; Hoshino, I; Isozaki, Y; Maruyama, T; Matsubara, H; Mori, M; Murakami, K; Nakayama, T; Nishimori, T; Suito, H; Suzuki, A; Takahashi, M; Takeshita, N; Toyozumi, T1
Gu, S; Hou, L; Huang, S; Liu, L; Luo, M; Meng, D; Zhang, X; Zhao, X; Zuo, X1
Guan, BX; Xu, XC; Ye, F; Zhang, GH1
Imamura, M; Itami, A; Kaganoi, J; Kawabe, A; Komoto, I; Li, ZG; Maeda, M; Sato, F; Shimada, Y1
Ai, N; Fang, MZ; Hou, Z; Lu, H; Sun, Y; Wang, Y; Welsh, W; Yang, CS1
Chin, KV; Hong, J; Hou, Z; Lee, MJ; Sang, S; Yang, CS; You, H1
Chen, L; Lee, MJ; Yang, CS1

Reviews

1 review(s) available for epigallocatechin gallate and Esophageal Neoplasms

ArticleYear
Inhibitory Effects of (-)-Epigallocatechin-3-gallate on Esophageal Cancer.
    Molecules (Basel, Switzerland), 2019, Mar-08, Volume: 24, Issue:5

    Topics: Antineoplastic Agents; Catechin; Cell Proliferation; DNA Methylation; Esophageal Neoplasms; Humans; Polyphenols; Signal Transduction; Tea

2019

Trials

1 trial(s) available for epigallocatechin gallate and Esophageal Neoplasms

ArticleYear
Phase II Trial of Epigallocatechin-3-Gallate in Acute Radiation-Induced Esophagitis for Esophagus Cancer.
    Journal of medicinal food, 2020, Volume: 23, Issue:1

    Topics: Adult; Aged; Catechin; Chemoradiotherapy; China; Esophageal Neoplasms; Esophagitis; Female; Humans; Male; Middle Aged; Prospective Studies; Radiation Injuries

2020

Other Studies

10 other study(ies) available for epigallocatechin gallate and Esophageal Neoplasms

ArticleYear
    Cells, 2022, Nov-30, Volume: 11, Issue:23

    Topics: Apoptosis; Cell Line, Tumor; Cell Movement; Esophageal Neoplasms; Genes, Tumor Suppressor; Humans; Intracellular Signaling Peptides and Proteins; NF-kappa B

2022
Epigallocatechin-3-gallate promotes apoptosis and reversal of multidrug resistance in esophageal cancer cells.
    Pathology, research and practice, 2017, Volume: 213, Issue:10

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; ATP Binding Cassette Transporter, Subfamily G, Member 2; Carcinoma, Squamous Cell; Catechin; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Membrane Potential, Mitochondrial; Neoplasm Proteins; Signal Transduction; Time Factors

2017
Enhancement of (-)-epigallocatechin-3-gallate and theaflavin-3-3'-digallate induced apoptosis by ascorbic acid in human lung adenocarcinoma SPC-A-1 cells and esophageal carcinoma Eca-109 cells via MAPK pathways.
    Biochemical and biophysical research communications, 2013, Aug-23, Volume: 438, Issue:2

    Topics: Adenocarcinoma; Anticarcinogenic Agents; Antineoplastic Agents; Apoptosis; Ascorbic Acid; Biflavonoids; Caspase 3; Caspase 9; Catechin; Cell Line, Tumor; Enzyme Inhibitors; Esophageal Neoplasms; Gallic Acid; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; MAP Kinase Signaling System

2013
Screening of alternative drugs to the tumor suppressor miR-375 in esophageal squamous cell carcinoma using the connectivity map.
    Oncology, 2014, Volume: 87, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Benzocaine; Betazole; Carcinoma, Squamous Cell; Catechin; Cell Line, Tumor; Chenodeoxycholic Acid; Cytotoxins; DNA Primers; Esophageal Neoplasms; Humans; In Situ Nick-End Labeling; Metformin; MicroRNAs; Nizatidine; Organophosphates; Proline; Protein Array Analysis; Real-Time Polymerase Chain Reaction; Rosiglitazone; Thiazolidinediones; Transcriptome; Transfection; Tumor Suppressor Proteins

2014
Molecular mechanism of epigallocatechin-3-gallate in human esophageal squamous cell carcinoma in vitro and in vivo.
    Oncology reports, 2015, Volume: 33, Issue:1

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Squamous Cell; Caspase 3; Catechin; Cell Line, Tumor; Cell Proliferation; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; G1 Phase Cell Cycle Checkpoints; Humans; Male; Mice, Inbred BALB C; Mice, Nude; Reactive Oxygen Species; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2015
Suppression of esophageal cancer cell growth using curcumin, (-)-epigallocatechin-3-gallate and lovastatin.
    World journal of gastroenterology, 2012, Jan-14, Volume: 18, Issue:2

    Topics: Animals; Anticarcinogenic Agents; Anticholesteremic Agents; Catechin; Cell Line, Tumor; Curcumin; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Esophageal Neoplasms; Extracellular Signal-Regulated MAP Kinases; Gene Expression; Humans; JNK Mitogen-Activated Protein Kinases; Lovastatin; Mice; Mice, Nude; Neoplasm Transplantation; Transplantation, Heterologous

2012
Inhibitory effects of epigallocatechin-3-gallate on N-nitrosomethylbenzylamine-induced esophageal tumorigenesis in F344 rats.
    International journal of oncology, 2002, Volume: 21, Issue:6

    Topics: Animals; Anticarcinogenic Agents; Catechin; Cyclin D1; Cyclooxygenase 1; Cyclooxygenase 2; Dimethylnitrosamine; Dinoprostone; Disease Models, Animal; DNA Primers; Enzyme-Linked Immunosorbent Assay; Esophageal Neoplasms; Esophagus; Isoenzymes; Male; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred F344; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Urokinase-Type Plasminogen Activator

2002
Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines.
    Cancer research, 2003, Nov-15, Volume: 63, Issue:22

    Topics: Adaptor Proteins, Signal Transducing; Anticarcinogenic Agents; Antineoplastic Agents; Carcinoma, Squamous Cell; Carrier Proteins; Catechin; Cell Division; Cell Line, Tumor; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Enzyme Inhibitors; Esophageal Neoplasms; Gene Expression Regulation, Neoplastic; Gene Silencing; Genes, p16; Humans; Models, Molecular; MutL Protein Homolog 1; Neoplasm Proteins; Nuclear Proteins; O(6)-Methylguanine-DNA Methyltransferase; Receptors, Retinoic Acid

2003
Mechanism of action of (-)-epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells.
    Cancer research, 2005, Sep-01, Volume: 65, Issue:17

    Topics: Benzopyrans; Biflavonoids; Carcinoma, Squamous Cell; Catechin; Cell Growth Processes; Cell Line, Tumor; Drug Stability; ErbB Receptors; Esophageal Neoplasms; Gallic Acid; Humans; Oxidation-Reduction; Phenols; Phosphorylation; Receptor, ErbB-2; Superoxide Dismutase

2005
Human salivary tea catechin levels and catechin esterase activities: implication in human cancer prevention studies.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 1999, Volume: 8, Issue:1

    Topics: Absorption; Adult; Anticarcinogenic Agents; Beverages; Capsules; Catechin; Drinking; Esophageal Neoplasms; Esterases; Female; Flavonoids; Free Radical Scavengers; Half-Life; Humans; Male; Middle Aged; Mouth Mucosa; Mouth Neoplasms; Saliva; Tea

1999